Age distribution of HPV genotypes in cervical intraepithelial neoplasia.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 21396686)

Published in Gynecol Oncol on March 11, 2011

Authors

Mario Sideri1, Sarah Igidbashian, Sara Boveri, Davide Radice, Chiara Casadio, Noemi Spolti, Maria Teresa Sandri

Author Affiliations

1: Preventive Gynaecology Unit, European Institute of Oncology, via Ripamonti 435, Milan, Italy.

Articles by these authors

Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat (2009) 1.93

Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods (2010) 1.81

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study. J Clin Oncol (2010) 1.63

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation (2002) 1.57

ABO blood group and cancer. Eur J Cancer (2010) 1.57

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol (2011) 1.56

Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. Ann Thorac Surg (2007) 1.50

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn (2011) 1.41

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab. Breast (2012) 1.39

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol (2006) 1.24

Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice. Oncology (2008) 1.17

The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling. EMBO Mol Med (2011) 1.16

Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol (2009) 1.15

The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res (2008) 1.14

Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Breast Cancer Res Treat (2005) 1.12

Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat (2007) 1.12

Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann Surg Oncol (2010) 1.10

Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. J Clin Virol (2009) 1.10

Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: an update. Clin Chem Lab Med (2007) 1.08

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila) (2010) 1.06

Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Res Treat (2008) 1.05

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer. Clin Breast Cancer (2010) 1.05

Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt) (2011) 1.04

Adrenocortical oncocytoma: case report. Clin Imaging (2003) 1.03

Role of biomarkers in chemotherapy-induced cardiotoxicity. Prog Cardiovasc Dis (2010) 1.00

The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci (2004) 1.00

A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol (2006) 1.00

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Clin Breast Cancer (2012) 0.98

Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol (2003) 0.98

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience. Gynecol Oncol (2010) 0.97

A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci (2005) 0.97

Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci (2011) 0.96

No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer (2010) 0.96

Interobserver variability of colposcopic interpretations and consistency with final histologic results. J Low Genit Tract Dis (2004) 0.96

Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience. Gynecol Oncol (2011) 0.94

The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies. Eur J Cardiothorac Surg (2010) 0.93

Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Res Treat (2004) 0.93

Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine (2009) 0.93

High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas. Br J Haematol (2007) 0.93

Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients. Oncol Rep (2011) 0.93

Does a personalized approach improve patient satisfaction in thoracic oncology? Am J Manag Care (2009) 0.92

A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Clin Cancer Res (2004) 0.92

Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PLoS One (2013) 0.92

Assessing appropriateness for elective colorectal cancer surgery: clinical, oncological, and quality-of-life short-term outcomes employing different treatment approaches. Int J Colorectal Dis (2011) 0.91

Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J Thorac Cardiovasc Surg (2007) 0.90

Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three-arm trial. Ann Surg Oncol (2014) 0.89

Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 0.88

Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study. Cancer (2003) 0.88

Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience. J Comput Assist Tomogr (2011) 0.87

Branchiogenic carcinoma--conceptual or true clinico-pathological entity? Cancer Treat Rev (2005) 0.87

Neuroendocrine differentiation in castration-resistant prostate cancer: a systematic diagnostic attempt. Clin Genitourin Cancer (2012) 0.87

Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects. Gynecol Endocrinol (2008) 0.87

HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test. Arch Virol (2013) 0.86

Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biol (2014) 0.83

Impaired quality of life after pneumonectomy: who is at risk? J Thorac Cardiovasc Surg (2009) 0.83

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. Contemp Clin Trials (2010) 0.83

Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics (2003) 0.83

Breast cancer among HIV-infected patients: the experience of the European Institute of Oncology. J Surg Oncol (2005) 0.83

Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. J Neurochem (2009) 0.82

"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancer. J Cancer Educ (2010) 0.82

Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: a model for Europe and Australia. Pharmacoeconomics (2002) 0.82

Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. Anticancer Res (2009) 0.82

Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases. Gynecol Oncol (2011) 0.82

"Salvage" surgery for primary mediastinal malignancies: is it worthwhile? J Thorac Oncol (2008) 0.81

The risk of pneumonectomy over the age of 70. A case-control study. Eur J Cardiothorac Surg (2007) 0.81

Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale. PLoS One (2013) 0.81

Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer. Curr Cancer Drug Targets (2008) 0.81

Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients. Leuk Lymphoma (2010) 0.81

Vulvar Lichen Sclerosus and Neoplastic Transformation: A Retrospective Study of 976 Cases. J Low Genit Tract Dis (2016) 0.81

Sentinel Pap smears in 261 invasive cervical cancer patients in Italy. Vaccine (2009) 0.80

Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist? Eur J Cardiothorac Surg (2008) 0.80

Circulating endothelial cell number and viability are reduced by exposure to high altitude. Endothelium (2008) 0.80

Predicting prolonged air leak after standard pulmonary lobectomy: computed tomography assessment and risk factors stratification. Surgeon (2010) 0.80

Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents. Oncology (2010) 0.80

The Impact of pelvimetry on anastomotic leakage in a consecutive series of open, laparoscopic and robotic low anterior resections with total mesorectal excision for rectal cancer. . Hepatogastroenterology (2014) 0.79

Prognostic value of circulating tumor cells in primary and metastatic breast cancer. Expert Rev Anticancer Ther (2012) 0.79

Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response. Breast (2007) 0.79

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. Infect Agent Cancer (2012) 0.79

Operative blood loss and use of blood products after full robotic and conventional low anterior resection with total mesorectal excision for treatment of rectal cancer. J Robot Surg (2010) 0.78

Who should be really considered as a poor mobilizer in the plerixafor era? Transfus Apher Sci (2012) 0.78

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study. J Clin Virol (2013) 0.78

The pitfalls of CA19-9: routine testing and comparison of two automated immunoassays in a reference oncology center. Am J Clin Pathol (2012) 0.78

Does chemotherapy increase the risk of respiratory complications after pneumonectomy? J Thorac Cardiovasc Surg (2006) 0.77

Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer. Cancer Chemother Pharmacol (2008) 0.77

Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation. Eur J Obstet Gynecol Reprod Biol (2007) 0.77